SCHEMBL22845012

SCHEMBL22845012

[N-]=[N+]=NCCOCCOCCOCCNC(=O)c1ccc(NC(=O)CCl)c(NC(=O)CCl)c1

nearest known ligand 0.48

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ SMN1; SMN2 Q16637 4/20 0.41
▸ CRBN Q96SW2 2/20 0.41
▸ HDAC1 Q13547 2/20 0.41
▸ HDAC3 O15379 1/20 0.41
▸ CA2 P00918 2/20 0.39
▸ HPGD P15428 2/20 0.38
▸ ALDH1A1 P00352 2/20 0.37
▸ HTT P42858 2/20 0.37
▸ NPC1 O15118 4/20 0.37
▸ RAB9A P51151 3/20 0.37
▸ HDAC2 Q92769 1/20 0.35
▸ MEN1 O00255 2/20 0.35
▸ KMT2A Q03164 2/20 0.35
▸ SCN1A P35498 1/20 0.34
▸ SCN2A Q99250 1/20 0.34
▸ SCN3A Q9NY46 1/20 0.34
▸ NAMPT P43490 1/20 0.34
▸ CYP1A2 P05177 1/20 0.33
▸ CYP2D6 P10635 1/20 0.33
▸ CYP2C9 P11712 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL29531296 1.00 SMN1; SMN2 (0.41) SMN1; SMN2CRBNHDAC1HDAC3CA2
SCHEMBL29872250 0.91 SMN1; SMN2 (0.41) SMN1; SMN2CRBNHDAC1HDAC3CA2
SCHEMBL22833140 0.91 SMN1; SMN2 (0.41) SMN1; SMN2CRBNHDAC1HDAC3CA2
SCHEMBL22845091 0.91 SMN1; SMN2 (0.41) SMN1; SMN2CRBNHDAC1HDAC3CA2
SCHEMBL29531265 0.91 SMN1; SMN2 (0.41) SMN1; SMN2CRBNHDAC1HDAC3CA2
SCHEMBL29531130 0.89 SMN1; SMN2 (0.51) SMN1; SMN2HDAC1HDAC3CA2HPGD
SCHEMBL29531490 0.83 CRBN (0.41) SMN1; SMN2CRBNHDAC1HDAC3CA2
SCHEMBL22845010 0.83 HDAC3 (0.47) SMN1; SMN2HDAC1HDAC3CA2HPGD
SCHEMBL29531240 0.81 CRBN (0.42) SMN1; SMN2CRBNCA2ALDH1A1HTT
SCHEMBL13698906 0.78 NPC1 (0.56) SMN1; SMN2CRBNHDAC1HDAC3CA2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2020260514-A1 BIS(2-HALOACETAMIDO)-COMPOUNDS FOR USE AS LINKING AGENTS AND RESULTANT PRODUCTS WHICH COMPRISE ANTIBODIES, HALF-ANTIBODIES AND ANTIBODY FRAGMENTS THE UNIVERSITY OF BATH (GB) 2020-12-30 — — WO disclosed
Send feedback